SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-062642
Filing Date
2018-10-18
Accepted
2018-10-18 06:09:14
Documents
5
Period of Report
2018-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36910_18k.htm 8-K 52969
2 EX-2.1 a18-36910_1ex2d1.htm EX-2.1 576494
3 EX-3.1 a18-36910_1ex3d1.htm EX-3.1 240903
4 EX-99.1 a18-36910_1ex99d1.htm EX-99.1 16997
5 GRAPHIC g369101mmi001.jpg GRAPHIC 2955
  Complete submission text file 0001104659-18-062642.txt   892808
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35050 | Film No.: 181127530
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences